The Potential Role of Viral Persistence in the Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) DOI Creative Commons
Lorenzo Lupi, Adriana Vitiello,

Cristina Parolin

и другие.

Pathogens, Год журнала: 2024, Номер 13(5), С. 388 - 388

Опубликована: Май 8, 2024

The infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated not only with the development of disease but also long-term symptoms or post-acute sequelae SARS-CoV-2 (PASC). Multiple lines evidence support that some viral antigens and RNA can persist for up to 15 months in multiple organs body, often after apparent clearance from upper system, possibly leading persistence symptoms. Activation immune system observed a prolonged time, providing indirect elements infection. In gastrointestinal tract, could stimulate shaping local microbiota potential systemic effects. All these interactions need be investigated, taking into account predisposing factors, multiplicity pathogenic mechanisms, stratifying populations vulnerable individuals, particularly women, children, immunocompromised where may present additional challenges.

Язык: Английский

Long COVID science, research and policy DOI Creative Commons
Ziyad Al‐Aly, Hannah Davis, Lisa McCorkell

и другие.

Nature Medicine, Год журнала: 2024, Номер 30(8), С. 2148 - 2164

Опубликована: Авг. 1, 2024

Long COVID represents the constellation of post-acute and long-term health effects caused by SARS-CoV-2 infection; it is a complex, multisystem disorder that can affect nearly every organ system be severely disabling. The cumulative global incidence long around 400 million individuals, which estimated to have an annual economic impact approximately $1 trillion-equivalent about 1% economy. Several mechanistic pathways are implicated in COVID, including viral persistence, immune dysregulation, mitochondrial dysfunction, complement endothelial inflammation microbiome dysbiosis. devastating impacts on individual lives and, due its complexity prevalence, also has major ramifications for systems economies, even threatening progress toward achieving Sustainable Development Goals. Addressing challenge requires ambitious coordinated-but so far absent-global research policy response strategy. In this interdisciplinary review, we provide synthesis state scientific evidence assess human health, systems, economy metrics, forward-looking roadmap.

Язык: Английский

Процитировано

130

Long COVID: a clinical update DOI
Trisha Greenhalgh, Manoj Sivan,

Alice Perlowski

и другие.

The Lancet, Год журнала: 2024, Номер 404(10453), С. 707 - 724

Опубликована: Июль 31, 2024

Язык: Английский

Процитировано

103

Mechanisms of long COVID and the path toward therapeutics DOI Creative Commons

Michael J. Peluso,

Steven G. Deeks

Cell, Год журнала: 2024, Номер unknown

Опубликована: Сен. 1, 2024

Язык: Английский

Процитировано

47

Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease DOI Creative Commons
Felicity Liew, Claudia Efstathiou, Sara Fontanella

и другие.

Nature Immunology, Год журнала: 2024, Номер 25(4), С. 607 - 621

Опубликована: Апрель 1, 2024

One in ten severe acute respiratory syndrome coronavirus 2 infections result prolonged symptoms termed long disease (COVID), yet phenotypes and mechanisms are poorly understood

Язык: Английский

Процитировано

45

Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection DOI
Michael J. Peluso,

Dylan Ryder,

Robert R. Flavell

и другие.

Science Translational Medicine, Год журнала: 2024, Номер 16(754)

Опубликована: Июль 3, 2024

The mechanisms of postacute medical conditions and unexplained symptoms after SARS-CoV-2 infection [Long Covid (LC)] are incompletely understood. There is growing evidence that viral persistence, immune dysregulation, T cell dysfunction may play major roles. We performed whole-body positron emission tomography imaging in a well-characterized cohort 24 participants at time points ranging from 27 to 910 days acute using the radiopharmaceutical agent [

Язык: Английский

Процитировано

39

Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control study DOI Creative Commons
Raphael S. Peter, Alexandra Nieters, Siri Goepel

и другие.

PLoS Medicine, Год журнала: 2025, Номер 22(1), С. e1004511 - e1004511

Опубликована: Янв. 23, 2025

Background Self-reported health problems following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are common and often include relatively non-specific complaints such as fatigue, exertional dyspnoea, concentration or memory disturbance sleep problems. The long-term prognosis of post-acute sequelae COVID-19/post-COVID-19 (PCS) is unknown, data finding correlating organ dysfunction pathology with self-reported symptoms in patients non-recovery from PCS scarce. We wanted to describe clinical characteristics diagnostic findings among persisting for >1 year assessed risk factors persistence versus improvement. Methods This nested population-based case-control study included subjects aged 18–65 years ( n = 982) age- sex-matched control without 576) according an earlier questionnaire (6–12 months after infection, phase 1) consenting provide follow-up information undergo comprehensive outpatient assessment, including neurocognitive, cardiopulmonary exercise, laboratory testing four university centres southwestern Germany (phase 2, another 8.5 [median, range 3–14 months] 1). mean age the participants was 48 years, 65% were female. At 67.6% at 1 developed persistent PCS, whereas 78.5% recovered remained free related PCS. Improvement associated mild index previous full-time employment, educational status, no specialist consultation not attending a rehabilitation programme. development new initially intercurrent secondary SARS-CoV-2 status. Patients less frequently never smokers (61.2% 75.7%), more obese (30.2% 12.4%) higher values body mass (BMI) fat, had lower status (university entrance qualification 38.7% 61.5%) than continued recovery. Fatigue/exhaustion, neurocognitive disturbance, chest symptoms/breathlessness anxiety/depression/sleep predominant symptom clusters. Exercise intolerance post-exertional malaise (PEM) >14 h compatible myalgic encephalomyelitis/chronic fatigue reported by 35.6% 11.6% patients, respectively. In analyses adjusted sex-age class combinations, centre qualification, significant differences between those recovery observed performance three different tests, scores perceived stress, subjective cognitive disturbances, dysautonomia, depression anxiety, quality, quality life. handgrip strength (40.2 [95% confidence interval (CI) [39.4, 41.1]] 42.5 CI [41.5, 43.6]] kg), maximal oxygen consumption (27.9 [27.3, 28.4]] 31.0 [30.3, 31.6]] ml/min/kg weight) ventilatory efficiency (minute ventilation/carbon dioxide production slope, 28.8 [28.3, 29.2]] 27.1 [26.6, 27.7]]) significantly reduced relative group adjustment centre, education, BMI, smoking use beta blocking agents. There measures systolic diastolic cardiac function rest, level N-terminal brain natriuretic peptide blood levels other measurements (including complement activity, markers Epstein–Barr virus [EBV] reactivation, inflammatory coagulation markers, serum cortisol, adrenocorticotropic hormone dehydroepiandrosterone sulfate). Screening viral (PCR stool samples spike antigen plasma) subgroup negative. Sensitivity (pre-existing illness/comorbidity, obesity, medical care infection) revealed similar findings. PEM pain worse results almost all tests. A limitation that we objective on exercise capacity cognition before infection. addition, did unable attend clinic whatever reason illness, immobility social deprivation exclusion. Conclusions this study, majority working recover second their illness. Patterns essentially similar, dominated complaints. Despite signs deficits capacity, there major investigations, our do support persistence, EBV adrenal insufficiency increased turnover pathophysiologically relevant history disease might help stratify cases severity.

Язык: Английский

Процитировано

7

Transfer of IgG from Long COVID patients induces symptomology in mice DOI Creative Commons
Hung‐Jen Chen, Brent Appelman, Hanneke L.D.M. Willemen

и другие.

bioRxiv (Cold Spring Harbor Laboratory), Год журнала: 2024, Номер unknown

Опубликована: Май 31, 2024

Abstract SARS-CoV-2 infections worldwide led to a surge in cases of Long COVID, post-infectious syndrome. It has been hypothesized that autoantibodies play crucial role the development COVID and other syndromes, such as fibromyalgia myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). In this study, we tested hypothesis by passively transferring total IgG from patients mice. Using Glial Fibrillary Acidic Protein (GFAP) type-I interferon expression, stratified into three subgroups, each with unique plasma proteome signatures. Remarkably, transfer two which are characterized higher levels neuronal proteins leukocyte activation markers, induced pronounced persistent sensory hypersensitivity distinct kinetics. Conversely, third subgroup, enriched skeletal cardiac muscle profiles, reduced locomotor activity mice without affecting their motor coordination. These findings demonstrate replicates disease symptoms, underscoring IgG’s causative pathogenesis. This work proposes murine model mirrors COVID’s pathophysiological mechanisms, may be used tool for screening developing targeted therapeutics.

Язык: Английский

Процитировано

17

Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort DOI
Kristine M. Erlandson, Linda N. Geng, Caitlin Selvaggi

и другие.

Annals of Internal Medicine, Год журнала: 2024, Номер 177(9), С. 1209 - 1221

Опубликована: Авг. 12, 2024

There are currently no validated clinical biomarkers of postacute sequelae SARS-CoV-2 infection (PASC).

Язык: Английский

Процитировано

16

The epithelial barrier theory and its associated diseases DOI Creative Commons
Na Sun, İsmail Öğülür, Yasutaka Mitamura

и другие.

Allergy, Год журнала: 2024, Номер unknown

Опубликована: Окт. 7, 2024

Abstract The prevalence of many chronic noncommunicable diseases has been steadily rising over the past six decades. During this time, 350,000 new chemical substances have introduced to lives humans. In recent years, epithelial barrier theory came light explaining growing and exacerbations these worldwide. It attributes their onset a functionally impaired triggered by toxicity exposed substances, associated with microbial dysbiosis, immune system activation, inflammation. Diseases encompassed share common features such as an increased after 1960s or 2000s that cannot (solely) be accounted for emergence improved diagnostic methods. Other traits include defects, dysbiosis loss commensals colonization opportunistic pathogens, circulating inflammatory cells cytokines. addition, practically unrelated fulfill criteria started emerge multimorbidities during last Here, we provide comprehensive overview discuss evidence similarities epidemiology, genetic susceptibility, dysfunction, tissue

Язык: Английский

Процитировано

16

The role of vasculature and angiogenesis in respiratory diseases DOI Creative Commons
Maximilian Ackermann, Christopher Werlein, Edith Plucinski

и другие.

Angiogenesis, Год журнала: 2024, Номер 27(3), С. 293 - 310

Опубликована: Апрель 5, 2024

Abstract In European countries, nearly 10% of all hospital admissions are related to respiratory diseases, mainly chronic life-threatening diseases such as COPD, pulmonary hypertension, IPF or lung cancer. The contribution blood vessels and angiogenesis regeneration, remodeling disease progression has been increasingly appreciated. vascular supply the shows peculiarity dual perfusion circulation (vasa publica), which maintains a functional blood-gas barrier, bronchial privata), reveals profiled capacity for (namely intussusceptive sprouting angiogenesis) alveolar-vascular by recruitment endothelial precursor cells. aim this review is outline importance in variety non-neoplastic neoplastic acute infection, fibrosis, hypertension

Язык: Английский

Процитировано

15